Molecular assay: Real-time PCR is used to detect RNA from SARS-CoV-2 virus.Emergent SARS-CoV-2 Variants

• Siemens-Healthineers has an ongoing Global Surveillance Program in place.

• Literature and the GISAID database are monitored to assess for new variants with the potential to affect the performance of the FTD SARS-CoV-2 Assay.

• The ORF1ab and the N gene of SARS-CoV-2 are used as targets in this assay.

• The FTD SARS-CoV-2 Assay detects the main variants and clades of SARS-CoV-2 (including alpha, beta, gamma, and delta) that are currently circulating with a 100% detection rate.

​

Features and Benefits:

• Kit comprised of a single-well dual-target assay for the specific detection of SARS-CoV-2 (COVID-19)

• Designed for high sensitivity, specificity, and inclusivity

• Covers highly conserved regions within ORF1ab and N gene

• Emergent SARS-CoV-2 variants are detected

• Uses the same assay setup protocol and thermal-cycling profile as all FTD respiratory disease kits

Click Here for more product information on our partner site